Stock Events

Stock Events

Purple Biotech 

$1.7500
26
-$0.23-11.62% Friday 20:00
-$0.08-4.57%Friday 23:59After hours

Statistics

Day High
1.78
Day Low
1.74
52W High
14.1
52W Low
1.16
Volume
1,907
Avg. Volume
-
Mkt Cap
2.85M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

9MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.37
-0.25
-0.12
0
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-26.39MNet Income

Analyst Ratings

17.00Average Price Target
The highest estimate is 17.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PPBT. It's not an investment recommendation.
Tesla
4
TSLA
Ford Motor
3
F
Realty Income
2
O
NVIDIA
2
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes in developing treatments for cancer, a key area of focus for Purple Biotech.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech firm with a strong emphasis on oncology and inflammatory disease treatments, directly competing with Purple Biotech's cancer therapy development.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines for cancer and other diseases, making it a direct competitor.
Merck
MRK
Mkt Cap366B
Merck & Co. focuses on cancer drugs and vaccines, which aligns with Purple Biotech's mission to develop novel treatments for cancer.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company with a broad portfolio that includes oncology, directly competing with Purple Biotech's cancer-focused therapies.
Novartis
NVS
Mkt Cap292.35B
Novartis is a healthcare company that engages in the research, development, and marketing of healthcare products, including cancer treatments, competing with Purple Biotech.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare with a strong emphasis on oncology, making it a competitor in the cancer treatment market.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for cancer.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for its innovative treatments in areas like oncology, directly competing with Purple Biotech's research and development efforts.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation specializes in oncology products, making it a competitor in the development of new cancer treatments.

About

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Show more...
CEO
Gil Efron
Employees
10
Country
Israel
ISIN
US74638P3073
WKN
000A423RM

Listings

STU
DE
1YI0.STU
TA
IL
PPBT.TA
MU
DE
1YI0.MU
XNAS
US
PPBT

0 Comments

Share your thoughts

FAQ

What is Purple Biotech stock price today?▼
The current price of PPBT is $1.75 USD — it has decreased by -11.62% in the past 24 hours. Watch Purple Biotech stock price performance more closely on the chart.
What is Purple Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Purple Biotech stocks are traded under the ticker PPBT.
Is Purple Biotech stock price growing?▼
PPBT stock has risen by +4.17% compared to the previous week, the month change is a +16.67% rise, over the last year Purple Biotech has showed a -73.48% decrease.
What is Purple Biotech market cap?▼
Today Purple Biotech has the market capitalization of 2.85M
What were Purple Biotech earnings last quarter?▼
PPBT earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Purple Biotech revenue for the last year?▼
Purple Biotech revenue for the last year amounts to 0 USD.
What is Purple Biotech net income for the last year?▼
PPBT net income for the last year is -26.39M USD.
How many employees does Purple Biotech have?▼
As of September 05, 2026, the company has 10 employees.
In which sector is Purple Biotech located?▼
Purple Biotech operates in the Health & Wellness sector.
When did Purple Biotech complete a stock split?▼
The last stock split for Purple Biotech was on March 02, 2026 with a ratio of 1:10.
Where is Purple Biotech headquartered?▼
Purple Biotech is headquartered in Rehovot, Israel.